Journey Medical Corporation (DERM) Q2 2026 Earnings Call Transcript
Journey Medical Corporation (DERM) Q1 2026 Earnings Call Transcript
Journey Medical Corporation (DERM) Q4 2025 Earnings Call Transcript
| Name | Quantity | Cost | Value | Profit ($) | Gain (%) |
|---|---|---|---|---|---|
| MA mason adams PVG ASSET MANAGEMENT Corp. | 79,573 | $422,819.61 | $506,880.01 | $84,060.4 | 19.88% |
| RAD Robert A. Dee AMERICAN FINANCIAL GROUP Inc. | 180,000 | $968,000 | $1.14M | $169,600 | 17.52% |
Hui Fai Tam Caitong International Asset Management Co. Ltd. | 11 | $78 | $70.4 | -$7.6 | -9.74% |
Christopher C. Powers Farther Finance Advisors, LLC | 6 | $42 | $38.22 | -$3.78 | -9% |
| JWM JPL Wealth Management LLC JPL Wealth Management, LLC | 2 | $13.7 | $13.44 | -$0.26 | -1.9% |
| Specialty Retail Industry | Consumer Discretionary Sector | Claude Maraoui CEO | NASDAQ (CM) Exchange | 48115J109 CUSIP |
| US Country | 58 Employees | - Last Dividend | - Last Split | - IPO Date |
Journey Medical Corporation, initially known as Coronado Dermatology, Inc., is a healthcare enterprise that has dedicated its efforts towards the development and commercialization of pharmaceutical products specifically targeted at treating dermatological conditions. Its operational base is in the United States, with its headquarters situated in Scottsdale, Arizona. Journey Medical Corporation functions as a subsidiary of Fortress Biotech, Inc., and has been in operation since its incorporation in the year 2014. The company has carved out a niche for itself in the dermatology domain by offering an array of treatment solutions ranging from medicated cloths for hyperhidrosis to oral and topical medications for acne and rosacea, among others.